Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections

Pediatrics

Volumn 100, Issue 1, 1997, Pages 65-71

  Halperin, S A ^a   Bortolussi, R ^a   Langley, J M ^a   Miller, B ^a   Eastwood, B J ^a  

^a IWK HEALTH CENTRE   (Canada)

Author keywords

Antimicrobial therapy; Bordetella pertussis; Erythromycin estolate; Pertussis; Whooping cough

Indexed keywords

ERYTHROMYCIN ESTOLATE;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; ERYTHROMYCIN ESTOLATE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; NASOPHARYNX; TIME FACTORS; WHOOPING COUGH;

EID: 0030794132     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.100.1.65     Document Type: Article

References (8)